As of 2025-03-16, the Relative Valuation of Evolus Inc (EOLS) is (15.12) USD. This relative valuation is based on P/E multiples. With the latest stock price at 13.20 USD, the upside of Evolus Inc based on Relative Valuation is -214.6%.
The range of the Relative Valuation is (13.10) - (16.60) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.5x - 21.8x | 19.9x |
| Forward P/E multiples | 16.1x - 20.9x | 18.2x |
| Fair Price | (13.10) - (16.60) | (15.12) |
| Upside | -199.2% - -225.8% | -214.6% |
| Date | P/E |
| 2025-03-14 | -16.65 |
| 2025-03-13 | -16.35 |
| 2025-03-12 | -16.93 |
| 2025-03-11 | -16.03 |
| 2025-03-10 | -15.99 |
| 2025-03-07 | -17.13 |
| 2025-03-06 | -17.03 |
| 2025-03-05 | -17.87 |
| 2025-03-04 | -18.10 |
| 2025-03-03 | -18.09 |
| 2025-02-28 | -18.40 |
| 2025-02-27 | -17.73 |
| 2025-02-26 | -18.06 |
| 2025-02-25 | -17.61 |
| 2025-02-24 | -17.80 |
| 2025-02-21 | -17.64 |
| 2025-02-20 | -18.44 |
| 2025-02-19 | -18.77 |
| 2025-02-18 | -18.65 |
| 2025-02-14 | -18.59 |
| 2025-02-13 | -18.97 |
| 2025-02-12 | -17.98 |
| 2025-02-11 | -17.37 |
| 2025-02-10 | -16.53 |
| 2025-02-07 | -16.53 |
| 2025-02-06 | -16.91 |
| 2025-02-05 | -17.11 |
| 2025-02-04 | -16.40 |
| 2025-02-03 | -16.37 |
| 2025-01-31 | -17.62 |
| 2025-01-30 | -17.92 |
| 2025-01-29 | -18.36 |
| 2025-01-28 | -17.95 |
| 2025-01-27 | -18.62 |
| 2025-01-24 | -17.95 |
| 2025-01-23 | -17.68 |
| 2025-01-22 | -17.82 |
| 2025-01-21 | -17.00 |
| 2025-01-17 | -13.26 |
| 2025-01-16 | -13.38 |
| 2025-01-15 | -12.70 |
| 2025-01-14 | -11.94 |
| 2025-01-13 | -12.36 |
| 2025-01-10 | -12.61 |
| 2025-01-08 | -12.88 |
| 2025-01-07 | -13.55 |
| 2025-01-06 | -13.87 |
| 2025-01-03 | -14.54 |
| 2025-01-02 | -14.01 |
| 2024-12-31 | -13.92 |